In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents

被引:46
作者
Neyts, J [1 ]
De Clercq, E [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1128/AAC.42.1.170
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have evaluated the susceptibility of the murine gamma herpesvirus 68 (MHV-68) to a variety of antiviral agents. The acyclic nucleoside phosphonate analogs cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine], (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA), and adefovir [9-(2-phosphonylmethoxyethyl)adenine] efficiently inhibited the replication of the virus in Vero cells (50% effective concentrations [EC(50)s], 0.008, 0.06, and 2.2 mu g/ml, respectively). Acyclovir, ganciclovir, and brivudin [(E)-5-(2-bromovinyl)-2'-deoxyuridine] had equipotent activities (EC(50)s, 1.5 to 8 mu g/ml), whereas foscarnet and penciclovir were less effective (EC(50)s, 23 and greater than or equal to 30 mu g/ml, respectively). The novel N-7-substituted nucleoside analog S2242 [7-(1,3-dihydroxy-2-propoxymethyl)purine] inhibited MHV-68 replication by 50% at 0.2 mu g/ml. The susceptibilities of MHV-68 and Epstein-Barr virus (EBV) to cidofovir, HPMPA, adefovir, and acyclovir were found to he comparable. However, for penciclovir, ganciclovir, brivudin, and S2242, major differences in the sensitivity of MHV-68 and EBV were observed, suggesting that MHV-68 is not always an optimal surrogate for the study of antiviral strategies for EBV. When evaluated with a model for lethal MHV-68 infections in mice with severe combined immunodeficiency, cidofovir proved to be very efficient in protecting against virus-induced mortality (100% survival at 50 days postinfection), whereas acyclovir, brivudin, and adefovir had little or no effect.
引用
收藏
页码:170 / 172
页数:3
相关论文
共 21 条
[1]  
ADUMA P, 1995, MOL PHARMACOL, V47, P816
[2]   COMPARATIVE ACTIVITY OF SELECTED ANTIVIRAL COMPOUNDS AGAINST CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS [J].
ANDREI, G ;
SNOECK, R ;
SCHOLS, D ;
GOUBAU, P ;
DESMYTER, J ;
DECLERCQ, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (12) :1026-1033
[3]   ACTIVITY OF PENCICLOVIR AGAINST EPSTEIN-BARR-VIRUS [J].
BACON, TH ;
BOYD, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1599-1602
[4]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[5]   MURINE HERPESVIRUS 68 IS GENETICALLY RELATED TO THE GAMMAHERPESVIRUSES EPSTEIN-BARR-VIRUS AND HERPESVIRUS SAIMIRI [J].
EFSTATHIOU, S ;
HO, YM ;
HALL, S ;
STYLES, CJ ;
SCOTT, SD ;
GOMPELS, UA .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :1365-1372
[6]   INHIBITORY EFFECTS OF ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS, INCLUDING (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE, ON EPSTEIN-BARR-VIRUS REPLICATION [J].
LIN, JC ;
DECLERCQ, E ;
PAGANO, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2440-2443
[7]   PROLONGED INHIBITORY EFFECT OF 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE AGAINST REPLICATION OF EPSTEIN-BARR VIRUS [J].
LIN, JC ;
SMITH, MC ;
PAGANO, JS .
JOURNAL OF VIROLOGY, 1984, 50 (01) :50-55
[8]   NOVEL ACYCLIC ADENOSINE-ANALOGS INHIBIT EPSTEIN-BARR VIRUS-REPLICATION [J].
LIN, JC ;
DECLERCQ, E ;
PAGANO, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1431-1433
[9]  
MEERBACH A, UNPUB INHIBITORY EFF
[10]  
Naesens L, 1997, ANTIVIR CHEM CHEMOTH, V8, P1